Search Results - "Stuetz, Anton"
-
1
NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo
Published in PloS one (30-07-2013)“…Melanoma is one of the most aggressive cancers and its incidence is increasing worldwide. So far there are no curable therapies especially after metastasis…”
Get full text
Journal Article -
2
Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application
Published in Drug metabolism and disposition (01-09-2008)“…Pimecrolimus and tacrolimus are calcineurin inhibitors used for the topical treatment of atopic dermatitis. Although structurally similar, they display…”
Get full text
Journal Article -
3
Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin
Published in Experimental dermatology (01-10-2005)“…: The permeabilities of normal human and normal, inflamed, or corticosteroid (CS) pretreated skin of young domestic pigs for pimecrolimus and tacrolimus were…”
Get full text
Journal Article -
4
Synthesis and Structure-Activity Relationships of Side-Chain-Substituted Analogs of the Allylamine Antimycotic Terbinafine Lacking the Central Amino Function
Published in Journal of medicinal chemistry (01-05-1995)“…Terbinafine is a therapeutically used inhibitor of fungal squalene epoxidase that has prompted extensive derivatization programs for structure-activity…”
Get full text
Journal Article -
5
Partnership Among Dermatology, the Society for Investigative Dermatology, and Industry: Suggestions for Change
Published in Journal of investigative dermatology (01-11-2007)Get full text
Journal Article -
6
SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7
Published in Experimental dermatology (01-07-2014)“…Netherton syndrome (NS; OMIM 256500) is a genetic skin disease resulting from defects in the serine protease inhibitor Kazal‐type 5 (SPINK5) gene, which…”
Get full text
Journal Article -
7
Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor
Published in Journal of investigative dermatology (01-08-2011)“…Basal cell carcinoma (BCC) is a distinctive manifestation in nevoid basal cell carcinoma syndrome (NBCCS) patients. Both inherited and acquired mutations of…”
Get full text
Journal Article -
8
Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
Published in The American journal of pathology (01-07-2008)“…Although vascular remodeling is a hallmark of many chronic inflammatory disorders, antivascular strategies to treat these conditions have received little…”
Get full text
Journal Article -
9
Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus
Published in International journal of pharmaceutics (09-01-2004)“…For treatment of skin diseases with topical drugs, penetration of the agents into the relevant layers of the skin is required. Permeation through the skin…”
Get full text
Journal Article -
10
Mechanical and Metabolic Injury to the Skin Barrier Leads to Increased Expression of Murine β-Defensin-1, -3, and -14
Published in Journal of investigative dermatology (01-02-2011)“…Protection of the skin against microbiological infection is provided by the permeability barrier and by antimicrobial proteins. We asked whether the expression…”
Get full text
Journal Article -
11
Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes
Published in Journal of investigative dermatology (01-11-2008)“…Calcineurin inhibitors are potent inhibitors of T-cell-receptor mediated activation of the adaptive immune system. The effects of this class of drug on the…”
Get full text
Journal Article -
12
Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics
Published in Journal of medicinal chemistry (01-01-1986)“…Naftifine (1) is the first representative of the new antifungal allylamine derivatives. Its biological activity is strictly bound to specific structural…”
Get full text
Journal Article -
13
Pharmacological Inhibition of Stearoyl CoA Desaturase in the Skin Induces Atrophy of the Sebaceous Glands
Published in Journal of investigative dermatology (01-08-2013)Get full text
Journal Article -
14
SPINK 5 knockdown in organotypic human skin culture as a model system for N etherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7
Published in Experimental dermatology (01-07-2014)“…Abstract Netherton syndrome ( NS ; OMIM 256500) is a genetic skin disease resulting from defects in the serine protease inhibitor K azal‐type 5 ( SPINK 5)…”
Get full text
Journal Article -
15
Corticosteroids But Not Pimecrolimus Affect Viability, Maturation and Immune Function of Murine Epidermal Langerhans Cells
Published in Journal of investigative dermatology (01-03-2004)“…Given the importance of dendritic cells in the immune response, we investigated the effect of corticosteroids (CS) on the integrity, survival, and function of…”
Get full text
Journal Article -
16
Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis
Published in Journal of Allergy and Clinical Immunology (01-06-2005)“…Apart from the long-used corticosteroids, topical calcineurin inhibitors (tacrolimus, pimecrolimus) represent novel therapeutic options for the treatment of…”
Get full text
Journal Article -
17
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids
Published in Experimental dermatology (01-10-2011)“…: It has been suggested that the increased rate of bacterial infection in atopic dermatitis (AD) may be caused by reduced antimicrobial protein (AMP)…”
Get full text
Journal Article -
18
Correction: NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
Published in PloS one (09-09-2013)Get full text
Journal Article -
19
Pimecrolimus for the treatment of inflammatory skin disease
Published in Expert opinion on pharmacotherapy (01-03-2004)“…Pimecrolimus (SDZ ASM 981, Elidel ) is an ascomycin macrolactam derivative and a cell-selective inhibitor of inflammatory cytokines specifically developed to…”
Get more information
Journal Article -
20
Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus
Published in International Archives of Allergy and Immunology (01-01-2006)“…Using a newly developed model of allergic contact dermatitis in pigs, calcineurin inhibitors of the tacrolimus and ascomycin type were shown to have a highly…”
Get full text
Journal Article